drugset / Trial / NCT00200473

A Study of the Safety and Efficacy of Nebivolol in Hypertensive Patients

NCT00200473

Phase 3 Completed 800 enrolled Mylan Bertek Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

A study to determine the safety, efficacy and superiority of nebivolol to placebo for the treatment of elevated blood pressure in patients with mild to moderate hypertension.

Timeline

Start
2001-09
Primary completion
Completion
2003-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Nebivolol Other / unclassified

Indications